Clinical Trials Directory

Trials / Terminated

TerminatedNCT05013073

ASTHMAXcel Emergency Department Study

Adapting the ASTHMAxcel ED Application to Improve Asthma Related Patient-Centered Outcomes and Health Care Resource Utilization

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
160 (actual)
Sponsor
Montefiore Medical Center · Academic / Other
Sex
All
Age
18 Years – 100 Years
Healthy volunteers
Not accepted

Summary

This protocol focuses on Phase 1 of a planned two-phase research project. Phase 1 aims to test and adapt a prototype ASTHMAXcelED application for the ED. Phase 2 will be an RCT to test the efficacy of a refined ASTHMAXcelED app after being modified based on the results of Phase 1.

Detailed description

The original ASTHMAxcel app was developed by Dr. Jariwala, which delivers asthma education and promotes patients' adherence to the national asthma guidelines. The app was developed in accordance with Montefiore Medical Center's regulatory/compliance (determined by the Montefiore Legal department and Einstein-Montefiore Office of Biotechnology) and security (determined by Montefiore IT) policies. Over the last several years the app has been iteratively improved based on patient feedback and has been shown to improve asthma knowledge, asthma control, and asthma-related quality of life among asthma clinic patients. This version of the app has been tailored to the ED, requiring less physician directed education and focusing on common triggers and symptom management. Research associates will ask each patient to download the ASTHMAXcelED app and RA's instruct them on use of the application. RA's will also show every patient a video using the ASTHMAXcelED mobile application in which the investigators demonstrate correct use of an inhaler and discuss asthma triggers.

Conditions

Interventions

TypeNameDescription
OTHERASTHMAXcel ED ApplicationA mobile application designed to assist patients in asthma symptom recognition, treatment best practices, and trigger identification.

Timeline

Start date
2021-05-01
Primary completion
2023-02-07
Completion
2023-02-07
First posted
2021-08-19
Last updated
2023-09-21

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT05013073. Inclusion in this directory is not an endorsement.